Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jun 6;22(1):163.
doi: 10.1186/s12874-022-01642-5.

Enhancing and assessing fidelity in the TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD) trial: development of methods and recommendations for research design

Steed L  1 , Wileman V  2 , Sohanpal R  2 , Kelly Mj  2 , Pinnock H  3 , Taylor Sjc  2
Affiliations
Multicenter Study

Enhancing and assessing fidelity in the TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD) trial: development of methods and recommendations for research design

Steed L et al. BMC Med Res Methodol. .

Abstract

Background: Development of complex interventions for management of chronic conditions has become increasingly common, with guidance now provided. Fidelity (whether the intervention is designed, delivered and received as intended) is critical to understanding if, and how an intervention works (or not). However, methods for achieving this are still evolving. This study describes the methods used in the TANDEM trial - a large multicentre study evaluating the impact of a cognitive behavioural intervention preceding routine pulmonary rehabilitation for people with chronic obstructive pulmonary disease and anxiety and or depression. Results for enhancement and training aspects of fidelity, are presented.

Methods: Using the National Institute for Health Behaviour Change Consortium (NIH BCC) framework of fidelity, a set of enhancement strategies and a fidelity measurement strategy were developed with input from a multidisciplinary team. The Cognitive First Aid Rating Scale (CFARS) was used to assess Facilitator (the respiratory professional delivering TANDEM) therapeutic competence at the end of the initial training and throughout treatment delivery (on a randomly selected set of cases). A TANDEM specific treatment adherence measure was developed following previously recommended procedures. Together these (the CFARS and adherence measure) comprised the TANDEM treatment delivery fidelity tool.

Results: Hiring of respiratory professionals to the initial training programme was successful, with 44% of those expressing initial interest in being a Facilitator successfully completing the process. Video recordings of potential Facilitators conducting standardized patient role plays at the end of the initial training demonstrated fidelity of training.

Conclusions: Addressing fidelity in complex intervention trials is a time and resource intensive process but has significant potential to increase understanding of results and strengthen the evidence base for effective interventions. By defining a full fidelity assessment method prior to analysis we aimed to minimise bias when interpreting results.

Trial registration: ISRCTN59537391 . Registered on 20 March 2017. Trial protocol version 6.0, 22 April 2018. Process evaluation protocol version 4.0, 1 November 2020.

Keywords: Anxiety; Assessment; COPD; Complex Intervention; Depression; Fidelity; Methodology; Therapeutic Competence.

PubMed Disclaimer

Conflict of interest statement

SJCT is the chief investigator or co-investigator on multiple previous and current research grants from the UK National Institute for Health Research and CRC UK. All authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Proposed Process of Fidelity incorporating NIH BCC fidelity domains [25, 26]
Fig. 2
Fig. 2
Enhancing Fidelity in TANDEM
Fig. 3
Fig. 3
Flow of Facilitators Throughout Recruitment
See this image and copyright information in PMC

References

    1. Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi: 10.7189/jogh.05.020415. - DOI - PMC - PubMed
    1. World Health Organisation. Global Health Estimates. 2019. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 9th Sept 2021
    1. Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Resp Jn. 2011;20(3):257–68. doi: 10.4104/pcrj.2011.00029. - DOI - PMC - PubMed
    1. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60–7. doi: 10.1001/archinte.167.1.60. - DOI - PubMed
    1. Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, Omachi TA. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229–34. doi: 10.1136/thx.2009.126201. - DOI - PMC - PubMed

Publication types

Associated data